Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For PROX.BR
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 34.93 0.98 0.73
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -2.77 7.70 7.92
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.43 10.58 10.23
Cash 35.90 3.02 2.22
Capex -11.59 -1.22 -1.10
Free Cash Flow 7.53 -0.31 0.29
Revenue -1.90 4.63 4.72
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 216.12 0.66 0.21
Operating Margin 18.57 0.11 0.09
ROA 5.03 < 0.005 < 0.005
ROE 8.51 0.03 0.03
ROIC -7.69 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of PROX.BR is permitted for members.
5 Growth
The "Growth Entry" for the Focus of PROX.BR is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of PROX.BR is permitted for members.